文献速递鼻科

生物可吸收缓释激素鼻窦支架用于额窦口疗效研究

[Studies on efficacy of a bioabsorbable steroid-eluting sinus stent in the frontal sinus opening of chronic rhinosinusitis with nasal polyps].
PubMed 文献 · Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2021-01-01

该研究纳入31例全组慢性鼻窦炎伴鼻息肉患者,采用自身对照设计,扩大性ESS后随机在一侧额窦口植入缓释糖皮质激素支架,另一侧为对照。术后30天支架组术后干预需求降低41.0%,口服激素干预降低40.0%,手术干预降低74.8%,额窦口通畅比例74.2%高于对照组48.4%,90天结果一致。

要点

  • 缓释激素支架可降低额窦口术后再干预需求。
  • 支架组额窦口通畅比例高于对照组。
  • 术后90天疗效与30天结果一致。

核心结论

  • 生物可吸收缓释糖皮质激素支架植入额窦口可减少息肉形成、粘连及术后干预需求,改善早期术后结局。

研究设计与样本

  • 自身对照随机设计,纳入2019年9月至2020年3月上海长海医院31例双侧病变相近的全组CRSwNP患者,男17例女14例,年龄(44.5±11.8)岁。

主要发现

  • 术后30天支架组需术后干预比例较对照组降低41.0%(χ2=5.314,P=0.021)。
  • 术后30天支架组口服糖皮质激素干预比例下降40.0%(χ2=4.133,P=0.042)。
  • 术后30天支架组手术干预比例下降74.8%(χ2=4.292,P=0.038)。
  • 术后30天支架组额窦口通畅比例74.2%高于对照组48.4%(χ2=4.351,P=0.037)。
  • 术后90天结果与30天一致。

临床怎么用

  • 全组CRSwNP患者扩大性ESS后可在额窦口植入缓释糖皮质激素支架以减少再干预并提高额窦口通畅性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To assess the efficacy of a bioabsorbable steroid-eluting sinus stent in improving surgical outcomes when placed in the frontal sinus ostium (FSO) following full endoscopic sinus surgery (ESS) in patients with whole group chronic rhinosinusitis with nasal polyps (CRSwNP). Methods: Patients with whole group CRSwNP who had similar lesions on bilateral sinus between September 2019 and March 2020 in Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Changhai Hospital were chosen. Patients with CRSwNP who underwent extended ESS were randomly assigned to receive a steroid-eluting sinus stent in one FSO whereas the contralateral side received surgery alone. Endoscopic evaluations recorded at 30, 90 days postoperative were graded by an independent assessment panel to assess the need for interventions in the FSO. Semi-quantitative data with CT and endoscopic score were performed by rank sum test. The need for postoperative intervention and the patency rate of FSO were analyzed using the McNemar test. Results: Thirty-one patients with whole group CRSwNP met all eligible criteria, including 17 males and 14 females, with the age of (44.5±11.8) years(x¯±s). Stents were successfully placed in one FSO of all patients. At 30 days post-ESS, the assessment panel reported that steroid-eluting stents reduced the need for postoperative interventions by 41.0% (χ2=5.314,P=0.021), the need for oral steroid interventions by 40.0% (χ2=4.133,P=0.042) and the need for surgical interventions by 74.8% (χ2=4.292,P=0.038) compared to control sinuses with no stents. Clinical surgeons also reported greater diameter of FSO compared to control sinuses at 30 days post-ESS (74.2% vs 48.4%, χ2=4.351, P=0.037). These results at 90 days post-ESS were consistent with those at 30 days post-ESS. Conclusion: Bioabsorbable steroid-eluting sinus stents in the FSO can reduce polyp formation, adhesion, and the need for postoperative interventions in FSO of CRSwNP patients and improve the early postoperative outcomes. 目的: 评估在全组慢性鼻窦炎伴鼻息肉(CRSwNP)患者额窦口植入缓释糖皮质激素支架(简称支架)对扩大性内镜鼻窦手术(ESS)后额窦术区创面恢复的疗效。 方法: 选取2019年9月至2020年3月在上海长海医院耳鼻咽喉头颈外科就诊的双侧病变程度相近的全组CRSwNP患者,采用自身对照设计,扩大性ESS后采用随机数据表法在一侧额窦术区植入支架,另一侧作为对照,术后第30、90天鼻内镜观察支架植入组与对照组额窦术区创面恢复情况。独立评估小组按照评估标准对鼻内镜检查结果进行评分,评估两组的治疗效果及额窦术区是否需要术后干预。CT及内镜评分半定量资料采用秩和检验,术后干预率、额窦口通畅度比例以计量资料统计,用配对四格表进行χ2检验。 结果: 共31例全组CRSwNP患者纳入研究,其中男性17例,女性14例,年龄(44.5±11.8)岁(x¯±s)。所有患者的一侧额窦口均成功植入支架。术后第30天鼻内镜检查结果显示:支架植入组需要术后干预的比例相比对照组降低了41.0%(χ2=5.314,P=0.021),其中口服糖皮质激素干预比例下降了40.0%(χ2=4.133,P=0.042),手术干预比例下降了74.8%(χ2=4.292,P=0.038);支架植入组较对照组具有更高的额窦口通畅比例(74.2%比48.4%,χ2=4.351,P=0.037)。术后第90天的结果与第30天一致。 结论: 缓释糖皮质激素的生物可降解支架在额窦术区的植入能有效降低术后再干预的可能,提高术后额窦口的通畅性。.

来源:Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Shi XQ, Tang HH, Zheng HL, et al. [Studies on efficacy of a bioabsorbable steroid-eluting sinus stent in the frontal sinus opening of chronic rhinosinusitis with nasal polyps]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021. PMID: 34521166. doi:10.3760/cma.j.cn115330-20200809-00655

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。